A year and a half ago, we raised an eyebrow when the government chose to indict the CEO of a drug company (InterMune) for allegedly illegal off-label promotion of the company’s drug. (We discussed the follow-on class action by purchasers of the drug here.)

The main event started in San Francisco on Tuesday. For coverage of the opening statements in the criminal trial against the former CEO, Scott Harkonen, see the AmLaw Daily here and The Recorder here (subscription required).